Evidence explainer

Diabetes and metabolic health

The Incretin System: How Gut Hormones Tell Your Body a Meal Has Arrived

Incretins are the gut hormones, chiefly GLP-1 and GIP, that your intestine releases within minutes of eating to say a meal is coming. They shape blood sugar, fullness, and modern diabetes care.

Fully reviewed by Jasaman (Jasmin) Tojjar, MD, PhD

On this page
  1. The short version
  2. Key points
  3. Two messengers, two neighborhoods of the gut
  4. The experiment that proved incretins exist
  5. What GLP-1 actually does at mealtime
  6. What changes in type 2 diabetes
  7. A few honest caveats

The short version#

An incretin is a hormone the gut releases in response to food that then amplifies the pancreas's insulin output. The two main ones, GLP-1 and GIP, are set free within minutes of a meal and act as an advance warning system: they reach the pancreas before the sugar does and prime it to release insulin in proportion to what was just eaten. GLP-1 goes further, slowing the stomach and signaling fullness to the brain. In short, incretins are the messengers that turn the plain act of eating into coordinated control of blood sugar and appetite.

Key points#

Two messengers, two neighborhoods of the gut#

Most of the incretin signal is carried by two hormones, and it helps to know where each one is made.

GIP, glucose-dependent insulinotropic polypeptide, comes largely from K cells near the top of the small intestine. Because those cells sit early in the digestive path, GIP tends to climb fast once food arrives.

GLP-1, glucagon-like peptide-1, comes largely from L cells lower down, in the far small intestine and the colon. GLP-1 is the more wide-ranging of the pair. It nudges the pancreas, but it also has a say over the stomach, the liver, and the brain.

Neither one is triggered by sugar alone. Fats and proteins set them off as well, which is part of why a full, mixed plate produces a fuller hormonal reply than a plain sugar drink would.

The experiment that proved incretins exist#

The cleanest evidence for this whole system is a comparison researchers have repeated for decades. Take a measured dose of glucose and have a person drink it. On a separate day, give the same person the same amount of glucose straight into a vein, dialed so the blood sugar rises along an identical curve. Because the blood sugar readings match, you would expect the insulin response to match too.

It does not. The glucose you swallow triggers far more insulin than the glucose delivered by vein. That difference has a name: the incretin effect. It reveals that the pancreas is not reacting to blood sugar by itself. It is also listening to the gut. Sugar traveling through the intestine sets off hormones that reach the pancreas ahead of the sugar and, in effect, tell it to get ready. Glucose sent by vein bypasses the gut, so that heads-up never gets sent. In a healthy person this gut-driven boost accounts for a large share of the insulin released after an ordinary meal.

What GLP-1 actually does at mealtime#

GLP-1 pulls several levers at once, and the coordination is elegant.

It ties insulin to glucose#

GLP-1 does not simply squeeze insulin out of the pancreas on command. It strengthens insulin release only while blood glucose is high, so the push is strong right after eating and fades on its own as sugar settles back toward baseline. That glucose dependence is a safety feature: the system leans in exactly when it is needed and lets go by itself, which is why the natural incretin response does not send blood sugar dangerously low.

It quiets the opposing signal#

The pancreas speaks with two voices. Beta cells release insulin to bring blood sugar down; alpha cells release glucagon, which raises it by prompting the liver to release stored glucose. After a meal you want the first voice up and the second down. When glucose is high, GLP-1 suppresses glucagon, so the liver stops adding sugar to a bloodstream the meal is already filling.

It slows the stomach#

GLP-1 slows gastric emptying, so food leaves the stomach more gradually. Glucose then enters the blood as a gentle ramp rather than a sudden spike, which is easier for the pancreas to keep pace with, and the after-meal sugar curve comes out flatter.

It reaches the brain and eases appetite#

GLP-1 also reaches brain regions that govern hunger and fullness, including the hypothalamus and the brainstem, and the message is satiety: the meal has landed and is being handled, so you can stop. Some of this signal comes from GLP-1 made in the gut, and some from GLP-1 produced by neurons in the brain itself. Either way, the dampening of appetite is a genuine part of normal physiology rather than a footnote.

What changes in type 2 diabetes#

Put those four actions together and you can see why the incretin system matters. It links one meal to more insulin when glucose is high, less glucagon, slower stomach emptying, and a lower drive to keep eating. Together they hold the after-meal rise in blood sugar to something modest and help mark the point where enough is enough.

In type 2 diabetes this coordinated reply weakens, and the incretin effect shrinks. Researchers have worked for years to separate two possible reasons: the gut releasing fewer hormones, or the pancreas responding less to the ones it gets. The current reading leans toward a blunted response at the pancreas, most clearly for GIP, with the GLP-1 signal somewhat better preserved. The picture is still being refined, and the work is genuinely hard, because hormones that act within minutes, in tissues that cannot be sampled easily in a living person, demand patient and clever experiments.

One thread worth keeping in mind is variation. Two people eating the same lunch can mount very different hormonal replies, shaped by genes, body composition, and the meal itself. A great deal of what looks like a single "normal" response is really a wide range, which is one reason metabolic research keeps circling back to how much individual biology hides inside an average.

A few honest caveats#

The incretin system is one instrument in a large ensemble. Insulin sensitivity in muscle and fat, the liver's handling of glucose, the nervous system, and the gut microbiome all take part, and no single hormone explains blood sugar or appetite on its own.

Questions about your own blood sugar, weight, or metabolism are best worked through with a clinician who knows your history.

The idea worth carrying away is simple. Eating is not just fuel arriving. It is a short exchange in which the gut speaks first, the pancreas and brain reply, and the incretin hormones are the words that pass between them.

Sources and further reading

  1. GLP-1 and GIP mechanisms review (Front Endocrinol 2024)
  2. Incretin effect oral vs IV glucose in T2D (PLoS ONE 2013)
  3. Incretin hormones GIP and GLP-1 comprehensive review (Int J Mol Sci 2025)

Questions and answers

Are incretins the same thing as insulin?

No. Insulin is made by the pancreas and lowers blood sugar directly. Incretins are gut hormones that tell the pancreas when and how strongly to release insulin. They set the timing and the volume; insulin does the work.

Why do incretin hormones rarely cause low blood sugar on their own?

Because their effect on insulin is glucose-dependent. GLP-1 strengthens insulin release mainly while blood glucose is elevated and eases off as it returns to baseline, so the natural response tends not to overshoot into hypoglycemia.

Do only carbohydrates trigger incretins?

No. Fats and proteins stimulate incretin release as well, which is why a mixed meal produces a broader hormonal response than a plain sugar load.